Role of the STAT1 pathway in apoptosis induced by fludarabine and JAK kinase inhibitors in B-cell chronic lymphocytic leukemia

REFERENCES

• Horvath CM. STAT proteins and transcriptional responses to extracellular signals. Trends Biochem Sci 2000;25:496–502.
   Google Scholar
• Bowman T, Garcia R, Turkson J, Jove R. STATs in oncogenesis. Oncogene 2000;19:2474 —2488.
   Google Scholar
• Benekli M, Baer MR, Baumann H, Wetzler M. Signal transducer and activator of transcription proteins in leuke-mias. Blood 2003;101:2940–2954.
   Google Scholar
• Lin TS, Mahajan S, Frank DA. STAT signaling in the pathogenesis and treatment of leukemias. Oncogene 2000;19:2496–2504.
   Google Scholar
• Ward AC, Touw I, Yoshimura A. The Jak-Stat pathway in normal and perturbed hematopoiesis. Blood 2000;95:19–29.
   Google Scholar
• Yu H, Jove R. The STATs of cancer—new molecular targets come of age. Nat Rev Cancer 2004;4:97–105.
   Google Scholar
• Schwaller J, Frantsve J, Aster J, Williams IR, Tomasson MH, Ross TS, Peeters P, Van Rompaey L, Van Etten RA, Ilaria R, Jr, et al. Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo-and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes. EMBO J 1998;17: 5321 —5333.
   Google Scholar
• Schwaller J, Parganas E, Wang D, Cain D, Aster JC, Williams IR, Lee CK, Gerthner R, Kitamura T, Frantsve J, et al. Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2. Mol Cell 2000;6: 693–704.
   Google Scholar
• Reed JC. Molecular biology of chronic lymphocytic leukemia: implications for therapy. Semin Hematol 1998;35:3–13.
   Google Scholar
• Reed JC. Molecular biology of chronic lymphocytic leuke-mia. Semin Oncol 1998;25:11— 18.
   Google Scholar
• Chiorazzi N, Ferrarini M. B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor. Annu Rev Immunol 2003;21:841 — 894.
   Google Scholar
• Frank DA, Mahajan S, Ritz J. B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT) 1 and STAT3 constitutively phosphorylated on serine residues. J Chin Invest 1997;100: 3140–3148.
   Google Scholar
• Frank DA, Mahajan S, Ritz J. Fludarabine-induced immu-nosuppression is associated with inhibition of STAT1 signaling. Nat Med 1999;5: 444— 447.
   Google Scholar
• Meydan N, Grunberger T, Dadi H, Shahar M, Arpaia E, Lapidot Z, Leeder JS, Freedman M, Cohen A, Gazit A, et al. Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature 1996;379:645— 648.
   Google Scholar
• Uckun FM, Ek 0, Liu XP, Chen CL. In vivo toxicity and pharmacokinetic features of the janus kinase 3 inhibitor WHI-P131 '4-(4'hydroxypheny1)-amino-6,7- dimethoxyqui-nazoline. Clin Cancer Res 1999;5: 2954–2962.
   Google Scholar
• Sudbeck EA, Liu XP, Narla RK, Mahajan S, Ghosh S, MaoC, Uckun FM. Structure-based design of specific inhibitors of Janus kinase 3 as apoptosis-inducing antileukemic agents. Clin Cancer Res 1999;5: 1569 — 1582.
   Google Scholar
• Gazit A, Osherov N, Posner I, Yaish P, Poradosu E, Gilon C, Levitzki A. Tyrphostins. 2. Heterocyclic and alpha-substi-tuted benzylidenemalononitrile tyrphostins as potent inhibitors of EGF receptor and ErbB2/neu tyrosine kinases. J Med Chem 1991;34: 1896— 1907.
   Google Scholar
• Wang LH, Kirken RA, Erwin RA, Yu CR, Farrar WL. JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response. J Immunol 1999;62: 3897 —3904.
   Google Scholar
• Goodman PA, Niehoff LB, Uckun FM. Role of tyrosine kinases in induction of the c-jun proto-oncogene in irradiated B-lineage lymphoid cells. J Biol Chem 1998;273:17742 — 17748.
   Google Scholar
• Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RI\4, Pals ST, van Oers MH. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells under-going apoptosis. Blood 1994;84:1415–1420.
   Google Scholar
• Schreiber E, Matthias P, Muller MM, Schaffner W. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res 1989;17:6419.
   Google Scholar
• Kanno Y, Kozak CA, Schindler C, Driggers PH, Ennist DL, Gleason SL, Darnell JE, Jr, Ozato K. The genomic structure of the murine ICSBP gene reveals the presence of the gamma interferon-responsive element, to which an ISGF3 alpha subunit (or similar) molecule binds. Mol Cell Biol 1993;13: 3951 —3963.
   Google Scholar
• Gimeno R, Codony-Servat J, Plana M, Rodriguez-Sanchez JL, Juarez C. Statl implication in the immune response to superantigens in vivo. J Immunol 1996;156:1378–1386.
   Google Scholar
• Tibbles HE, Vassilev A, Wendorf H, Schonhoff D, Zhu D, Lorenz D, Waurzyniak B, Liu XP, Uckun FM. Role of a JAK3-dependent biochemical signaling pathway in platelet activation and aggregation. J Biol Chem 2001;276: 17815 — 17822.
   Google Scholar
• Robertson LE, Chubb S, Meyn RE, Story M, Ford R, Hittelman WN, Plunkett W. Induction of apoptotic cell death in chronic lymphocytic leukemia by 2-chloro-2'-deoxyadenosine and 9-beta-D-arabinosy1-2-fluoroadenine. Blood 1993;81: 143–150.
   Google Scholar
• Friedberg JW, Dong DA, Li S, Kim H, Stephans K, Noonan K, Neuberg D, Gribben JG, Fisher DC, Freedman AS, Takvorian T, Jurgens R, Battle TE, Frank DA. Oral fludarabine has significant activity in patients with pre-viously untreated chronic lymphocytic leukemia, and leads to increased STAT1 levels in vivo. Leuk Res 2004;28:139 — 147.
   Google Scholar
• Levitzki A. Tyrphostins— potential antiproliferative agents and novel molecular tools. Biochem Pharmacol 1990;40: 913–918.
   Google Scholar
• Amin HM, Medeiros LJ, Ma Y, Feretzaki M, Das P, Leventaki V, Rassidakis GZ, O'Connor SL, McDonnell TJ, Lai R. Inhibition of JAK3 induces apoptosis and decreases anaplastic lymphoma kinase activity in anaplastic large cell lymphoma. Oncogene 2003;22: 5399 —5407.
   Google Scholar
• Igarashi K, Garotta G, Ozmen L, Ziemiecki A, Wilks AF, Harpur AG, Lamer AC, Finbloom DS. Interferon-gamma induces tyrosine phosphorylation of interferon-gamma re-ceptor and regulated association of protein tyrosine kinases, Jakl and Jak2, with its receptor. J Biol Chem 1994;269: 14333–14336.
   Google Scholar
• Buschle M, Campana D, Carding SR, Richard C, Hoffbrand AV, Brenner MK. Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia. J Exp Med 1993;177:213–218.
   Google Scholar
• Dancescu M, Rubio-Trujillo M, Biron G, Bron D, Dele-spesse G, Sarfati M. Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bc1-2 expression. J Exp Med 1992;176:1319 — 1326.
   Google Scholar
• Francia di Celle P, Mariani S, Riera L, Stacchini A, Reato G, Foa R. Interleukin-8 induces the accumulation of B-cell chronic lymphocytic leukemia cells by prolonging survival in an autocrine fashion. Blood 1996;87:4382–4389.
   Google Scholar
• Frishman J, Long B, Knospe W, Gregory S, Plate J. Genes for interleukin 7 are transcribed in leukemic cell subsets of individuals with chronic lymphocytic leukemia. J Exp Med 1993;177: 955–964.
   Google Scholar